[go: up one dir, main page]

GB201006938D0 - Granulysin and derived peptides:use as novel anthelmintic molecules - Google Patents

Granulysin and derived peptides:use as novel anthelmintic molecules

Info

Publication number
GB201006938D0
GB201006938D0 GBGB1006938.3A GB201006938A GB201006938D0 GB 201006938 D0 GB201006938 D0 GB 201006938D0 GB 201006938 A GB201006938 A GB 201006938A GB 201006938 D0 GB201006938 D0 GB 201006938D0
Authority
GB
United Kingdom
Prior art keywords
granulysin
molecules
derived peptides
novel anthelmintic
anthelmintic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB1006938.3A
Other versions
GB2479212A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CRAIG NICOLA M
Original Assignee
CRAIG NICOLA M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CRAIG NICOLA M filed Critical CRAIG NICOLA M
Publication of GB201006938D0 publication Critical patent/GB201006938D0/en
Publication of GB2479212A publication Critical patent/GB2479212A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56905—Protozoa
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
    • G01N2333/43526—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms
    • G01N2333/4353—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from worms from nematodes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Disclosed are uses of granulysin, its variants, isoforms and homologues, or peptides derived by alteration of granulysin, its variants, isoforms or its homologues, in methods of diagnosing, preventing or treating helminth infections.
GB1006938A 2010-03-29 2010-04-26 Granulysin for the treatment of helminth infections Withdrawn GB2479212A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1005262.9A GB201005262D0 (en) 2010-03-29 2010-03-29 Granulysin and derived peptides: use as novel anthelmintic molecules

Publications (2)

Publication Number Publication Date
GB201006938D0 true GB201006938D0 (en) 2010-06-09
GB2479212A GB2479212A (en) 2011-10-05

Family

ID=42228530

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB1005262.9A Ceased GB201005262D0 (en) 2010-03-29 2010-03-29 Granulysin and derived peptides: use as novel anthelmintic molecules
GB1006938A Withdrawn GB2479212A (en) 2010-03-29 2010-04-26 Granulysin for the treatment of helminth infections

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB1005262.9A Ceased GB201005262D0 (en) 2010-03-29 2010-03-29 Granulysin and derived peptides: use as novel anthelmintic molecules

Country Status (1)

Country Link
GB (2) GB201005262D0 (en)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8288509B2 (en) * 2002-02-22 2012-10-16 National Hospital Organization Kinki-chuo Chest Medical center Therapeutic agent for infections, and treatment method using the same
WO2006088945A2 (en) * 2005-02-14 2006-08-24 The Regents Of The University Of California Granulysin peptides and methods of use thereof
US7745390B2 (en) * 2005-05-23 2010-06-29 The Board Of Trustees Of The Leland Stanford Junior University Antimicrobial peptides

Also Published As

Publication number Publication date
GB201005262D0 (en) 2010-05-12
GB2479212A (en) 2011-10-05

Similar Documents

Publication Publication Date Title
EA201291031A1 (en) METHOD OF TREATING OBESITY WITH THE USE OF ANTIOXIDANT INFLAMMATION MODULATORS
EA201270722A1 (en) RIFAXIMINE FORMS AND THEIR APPLICATION
EA201101521A1 (en) METHODS OF TREATMENT OF ONCOLOGICAL DISEASES, USING EPIMETABOLIC SWITCHES, MULTIPLE-DIFFERENT INTRACELLULAR MOLECULES OR IMPACT FACTORS
TN2012000366A1 (en) Anticoagulant antidotes
MX381456B (en) Transduction buffer
PH12012501841B1 (en) Anti-infective compounds
MA32161B1 (en) Rifaximin forms and uses thereof
EP4582090A3 (en) Composition comprising pegylated arginine deiminase
MY169328A (en) Compositions for the treatment of dry eye
EA201390274A1 (en) Boron-containing small molecules
MX359854B (en) Anti-cxcr3 antibodies.
MX349886B (en) Anti-pseudomonas psl binding molecules and uses thereof.
WO2014076321A8 (en) Novel specific-binding polypeptides and uses thereof
MX391136B (en) Cysteine-stabilized OspA fragments and method of use
MX2019006620A (en) POLYSACCHARIDES COMPOSITIONS AND METHODS OF USE.
EA201201623A1 (en) TREATMENT OF DIABETES TYPE 2
MX359181B (en) Collagen hydrolysate and use thereof.
IN2014DN08385A (en)
EA201590503A1 (en) ALPHA-1-Microglobulin for use in the treatment of diseases associated with mitochondria
PH12013501924A1 (en) Anticoagulant antidotes
MX358132B (en) Thrombin solution and methods of use thereof.
HK1213500A1 (en) Novel approaches for individualized therapy of pancreatic ductal adenocarcinoma
EA201590782A1 (en) ОКСИРАНОВЫЕ АМИНЫ
GB201006938D0 (en) Granulysin and derived peptides:use as novel anthelmintic molecules
WO2014004178A3 (en) Compositions comprising substituted phenols and topical application thereof

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)